CN109917036A - Gentamicin procaine ties up the HPLC-ELSD detection method of gentamicin C components content in B12 capsule - Google Patents

Gentamicin procaine ties up the HPLC-ELSD detection method of gentamicin C components content in B12 capsule Download PDF

Info

Publication number
CN109917036A
CN109917036A CN201910230015.XA CN201910230015A CN109917036A CN 109917036 A CN109917036 A CN 109917036A CN 201910230015 A CN201910230015 A CN 201910230015A CN 109917036 A CN109917036 A CN 109917036A
Authority
CN
China
Prior art keywords
gentamicin
content
capsule
component
procaine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910230015.XA
Other languages
Chinese (zh)
Other versions
CN109917036B (en
Inventor
卢日刚
朱健萍
朱荣
赵庄
黄丽丽
陈瀚
谭菊英
邓鸣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangxi Zhuang Autonomous Region Institute Of Food And Drug Control
Original Assignee
Guangxi Zhuang Autonomous Region Institute Of Food And Drug Control
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangxi Zhuang Autonomous Region Institute Of Food And Drug Control filed Critical Guangxi Zhuang Autonomous Region Institute Of Food And Drug Control
Priority to CN201910230015.XA priority Critical patent/CN109917036B/en
Publication of CN109917036A publication Critical patent/CN109917036A/en
Application granted granted Critical
Publication of CN109917036B publication Critical patent/CN109917036B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention belongs to field of chemical detection, more particularly to the HPLC-ELSD detection method of gentamicin C components content in a kind of gentamicin procaine dimension B12 capsule, including (1) chromatographic condition and system suitability (2) solution prepare (3) measurement.This method is easy to operate, detection efficiency is high, error is small, the method of inspection is more stable, accuracy, precision, specificity, detection limit, durability of this method etc. meet methodology validation requirement, with very strong practicability, the content of gentamicin C components in gentamicin procaine dimension B12 capsule can be quickly detected, thus the effectively quality of control gentamicin procaine dimension B12 capsule.

Description

Gentamicin procaine ties up the HPLC- of gentamicin C components content in B12 capsule ELSD detection method
Technical field
The invention belongs to field of chemical detection, and in particular to celebrating is big mould in a kind of gentamicin procaine dimension B12 capsule The HPLC-ELSD detection method of plain component C content.
Background technique
Gentamicin procaine dimension B12 capsule (former name gastritis capsule also known as gentamicin procaine capsule, with The compound mouth being made of gentamicin sulphate, procaine hydrochloride, vitamin B12 and appropriate amount of auxiliary materials down referred to as " capsule ")) Formulation.Wherein, gentamicin sulphate is aminoglycoside antibiotics, to various gram-negative bacterias, gram-positive bacteria and Helicobacter pylori has antibacterial action, can inhibit helicobacter pylori, plays local bactericidal effect under one's belt;Hydrochloric acid Proca For local anaesthetics, sealing process can be played to the nerve endings on damaging mucosal surface, block the stimulation of lesion Central nervous system, from And rapid pain relief;Vitamin B12 is substance necessary to form alimentary canal normal epithelium cell.Three's cooperation can be played anti- Bacterium, analgesic and the effect for promoting gastric mucosal, are used clinically for alleviating acute and chronic gastritis symptom and anti-inflammatory, analgesic, promotion Stomach lining reparation.
Gentamicin procaine ties up B12 capsule current standard as the rising of " national drug standards " chemicals provincial standard National standard (the 6th) WS-10001-(HD-0524) -2002, State Food and Drug Administration standard YBH15222004 With State Food and Drug Administration standard YBH20972006, the detection in three parts of standards for gentamicin sulphate has The identification (WS-10001-(HD-0524) -2002 of sulfate), thin layer identify (YBH15222004, YBH20972006) and Assay, the Con trolling index without its component.Gentamicin sulphate is aminoglycoside antibiotics, is with gentamicinC1、C1a、 C2、C2aEtc. mixture based on components, no UV absorption.Main pharmacodynamics ingredient one of of the gentamicin sulphate as this product, mark Lack corresponding inspection item in standard, is a undoubtedly major hidden danger for the control of product quality.
Summary of the invention
The purpose of the present invention is in view of the shortcomings of the prior art and provide a kind of gentamicin procaine tie up B12 The HPLC-ELSD detection method of gentamicin C components content in capsule ties up B12 to gentamicin procaine using this method The content of gentamicin C components is measured in capsule, easy to operate, and detection efficiency is high, and error is small, can quickly detect to celebrate The content of big mycin component C, thus the effectively quality of control gentamicin procaine dimension B12 capsule.
To achieve the above object, the present invention adopts the following technical scheme that:
A kind of gentamicin procaine ties up the HPLC-ELSD detection method of gentamicin C components content in B12 capsule, including Following steps:
(1) chromatographic condition and system suitability:
It is filler, Shiseido ACR C18 4.6 × 250mm, 5 μm of chromatographic columns, with first with octadecylsilane chemically bonded silica Alcohol is mobile phase A, and 0.02mol/L trifluoroacetic acid is Mobile phase B, carries out gradient elution, flow velocity 1ml/min, column temperature 30 by table 1 DEG C, atomization temperature is 70 DEG C, air velocity 1.6SLM, and gentamicin standard solution chromatogram should be consistent with standard diagram;
(2) prepared by solution:
The preparation of gentamicin sulphate standard solution
Gentamicin sulphate standard items 100mg is taken, it is accurately weighed, it is placed in 10mL measuring bottle, scale is dissolved and be diluted to water, is shaken It is even, it is accurate respectively to measure 1,3,5mL, it is diluted with water to 10mL, is shaken up, concentration, which is made, respectively may be about 1mg/mL, 3mg/mL, 5mg/ The standard solution of mL is 1., 2., 3.;
The preparation of test solution:
It takes this product content to mix, weighs in right amount, be equivalent to average loading amount, accurately weighed, precision plus water 5mL, shaking make sulfuric acid Gentamicin dissolution, filtering take subsequent filtrate as test solution;
(3) it measures:
Precision measures standard solution, and 1., 2., 3. each 20 μ L according to above-mentioned chromatographic condition is injected separately into liquid chromatograph, records Chromatogram calculates the equation of linear regression of standard solution each component log concentration value and corresponding peak area logarithm, phase relation Number (r) is not less than 0.99;It takes test solution to be measured in the same method, calculates separately confession with the equation of linear regression of gentamicin each component Amount (the C of component is corresponded in test producttcx), and calculate by following formula the content (%, u/u) of each component;
In formula, Cx is the content %, u/u of gentamicin each component;CtcxContent for each component gone out by regression equation calculation mg/ml;It is averaged loading amount g for test sample;W is test sample sampling amount mg;V is test sample extension rate;Labelled amount is in terms of g.
C1Should be labelled amount 15.3%~28.0%, C1aIt should be 19.6%~48.0%, C of labelled amount2a+C2It should be mark The 28.5%~63.8% of amount, four component total contents are not less than labelled amount 85%.
The invention has the benefit that
The HPLC-ELSD inspection of gentamicin C components content in a kind of gentamicin procaine dimension B12 capsule provided by the invention Survey method, this method is easy to operate, and detection efficiency is high, and error is small, and the method for inspection is more stable, the accuracy of the method for the present invention, essence Density, specificity, detection limit, durability etc. meet methodology validation requirement, have very strong practicability, can quickly detect Gentamicin procaine ties up the content of gentamicin C components in B12 capsule out, to effectively control gentamicin Proca Because tieing up the quality of B12 capsule.
Detailed description of the invention
Fig. 1 is to tie up B12 capsule sample to 47 batch gentamicin procaines using detection method to be measured The four component total content distribution map of gentamicin sulphate obtained;
Fig. 2 is to be measured to obtain to 47 batch gentamicin procaines dimension B12 capsule sample using detection method Gentamicin sulphate C1Constituent content distribution map;
Fig. 3 is to be measured to obtain to 47 batch gentamicin procaines dimension B12 capsule sample using detection method Gentamicin sulphate C1aConstituent content distribution map;
Fig. 4 is to be measured to obtain to 47 batch gentamicin procaines dimension B12 capsule sample using detection method Gentamicin sulphate C2+C2aContent distribution figure;
Fig. 5 is to tie up B12 capsule sample to the gentamicin procaine that 4 enterprises produce using detection method to survey Surely the 4 enterprise's sample gentamicin sulphate total content average value comparison diagrams obtained;
Fig. 6 is to tie up B12 capsule sample to the gentamicin procaine that 4 enterprises produce using detection method to survey Surely the 4 enterprise sample gentamicin sulphate C obtained1aConstituent content average value comparison diagram;
Fig. 7 is to tie up B12 capsule sample to the gentamicin procaine that 4 enterprises produce using detection method to survey Surely the 4 enterprise sample gentamicin sulphate C obtained1Constituent content average value comparison diagram;
Fig. 8 is to tie up B12 capsule sample to the gentamicin procaine that 4 enterprises produce using detection method to survey Surely the 4 enterprise sample gentamicin sulphate C obtained2+C2aConstituent content average value comparison diagram;
Fig. 9 is that gentamicin procaine ties up gentamicin sulphate compound mensuration typical case's map in B12 capsule.
Specific embodiment
Embodiment 1
One, a kind of gentamicin procaine ties up the HPLC-ELSD detection method of gentamicin C components content in B12 capsule, packet Include following steps:
(1) chromatographic condition and system suitability:
It is filler, Shiseido ACR C18 4.6 × 250mm, 5 μm of chromatographic columns, with first with octadecylsilane chemically bonded silica Alcohol is mobile phase A, and 0.02mol/L trifluoroacetic acid is Mobile phase B, carries out gradient elution, flow velocity 1ml/min, column temperature 30 by table 1 DEG C, atomization temperature is 70 DEG C, air velocity 1.6SLM, and gentamicin standard solution chromatogram should be consistent with standard diagram;
(2) prepared by solution:
The preparation of gentamicin sulphate standard solution
Gentamicin sulphate standard items 100mg is taken, it is accurately weighed, it is placed in 10mL measuring bottle, scale is dissolved and be diluted to water, is shaken It is even, it is accurate respectively to measure 1,3,5mL, it is diluted with water to 10mL, is shaken up, concentration, which is made, respectively may be about 1mg/mL, 3mg/mL, 5mg/ The standard solution of mL is 1., 2., 3.;
The preparation of test solution:
It takes this product content to mix, weighs in right amount, be equivalent to average loading amount, accurately weighed, precision plus water 5mL, shaking make sulfuric acid Gentamicin dissolution, filtering take subsequent filtrate as test solution;
(3) it measures:
Precision measures standard solution, and 1., 2., 3. each 20 μ L according to above-mentioned chromatographic condition is injected separately into liquid chromatograph, records Chromatogram calculates the equation of linear regression of standard solution each component log concentration value and corresponding peak area logarithm, phase relation Number (r) is not less than 0.99;It takes test solution to be measured in the same method, calculates separately confession with the equation of linear regression of gentamicin each component Amount (the C of component is corresponded in test producttcx), and calculate by following formula the content (%, u/u) of each component;
In formula, Cx is the content %, u/u of gentamicin each component;CtcxContent for each component gone out by regression equation calculation mg/ml;It is averaged loading amount g for test sample;W is test sample sampling amount mg;V is test sample extension rate;Labelled amount is in terms of g.
Two, the HPLC-ELSD of gentamicin C components content is detected in gentamicin procaine dimension B12 capsule of the present invention The methodology validation situation of method is as follows:
1, linear relationship is investigated
Take gentamicin sulphate standard items (lot number 130326-201716, C1 content 15.9%, C1a content 15.2%, C2 content 16.9%, C2a content 10.3%;There is provided by National Institute for Food and Drugs Control) 200mg, it is accurately weighed, it is placed in 20mL measuring bottle In, scale is dissolved and be diluted to water, is shaken up, it is accurate respectively to measure 0.5,1,2.5,5,10mL, it is diluted with water to 10mL, is shaken It is even, be made concentration respectively may be about 0.5 μ g/mL, 1 μ g/mL, 2.5 μ g/mL, 5 μ g/mL, 10 μ g/mL linear work solution (1), (2), (3), (4), (5).Precision measures linear work solution (1), (2), (3), (4), (5) each 20 μ L, is injected separately into liquid phase color Spectrometer records chromatogram, carries out linear regression to corresponding peak area logarithm with each component log concentration value, the results are shown in Table 2.Knot Fruit shows that gentamicin each component linear relationship within the scope of respective concentration is good.
2, instrument sample introduction precision is investigated
Above-mentioned linear work solution (3) is taken, 5 needle of continuous sample introduction, the RSD of 4 components is respectively 2.4%, 3.4%, 0.6%, 2.4%, It the results are shown in Table 3.
3, stability of solution is investigated
Take (Haikou Qili Pharmaceutical Co., Ltd.'s production, lot number 171101) by the preparation of test solution in the method for the present invention Method carries out preparing test solution, detects under the chromatographic condition limited in the methods of the invention, as the result is shown each group in solution Point good in 12 hours internal stabilities, the RSD of tetra- components of C1a, C2, C2a, C1 is respectively 2.0%, 4.7%, 6.2%, 3.5%, knot Fruit is shown in Table 4.
4, the rate of recovery is investigated
Take gentamicin sulphate (production of North China Hua Luan Co., Ltd, pharmacy group, lot number Q160604) in right amount, it is accurately weighed, point It is not dissolved in water and standard solution L, M, H that concentration is about 0.5mg/mL, 1mg/mL, 1.5mg/mL is made;
The rate of recovery investigate solution L: take gentamicin procaine dimension B12 capsule (Haikou Qili Pharmaceutical Co., Ltd. production, Lot number 171101) content mixing, it weighs appropriate (being approximately equivalent to gentamicin sulphate 5mg), accurately weighed, 10mL is added in precision Standard solution L, shaking dissolve gentamicin sulphate, filter, take subsequent filtrate.
The rate of recovery investigates solution M: weighing content in right amount (being approximately equivalent to gentamicin sulphate 10mg), accurately weighed, essence Close addition 10mL standard solution M, shaking dissolve gentamicin sulphate, filter, take subsequent filtrate.
The rate of recovery investigates Solution H: weighing content in right amount (being approximately equivalent to gentamicin sulphate 15mg), accurately weighed, essence Close addition 10mL standard solution H, shaking dissolve gentamicin sulphate, filter, take subsequent filtrate.
The rate of recovery of each concentration investigates solution and prepares 3 parts in parallel, examines under the chromatographic condition limited in the methods of the invention It surveys, the results are shown in Table 5.The result shows that the rate of recovery is good, method is feasible.
5, repeatability is investigated
Take gentamicin procaine dimension B12 capsule (Haikou Qili Pharmaceutical Co., Ltd.'s production, lot number 171101) content Object is made repeatability by the preparation method of test solution in the method for the present invention and investigates 6 parts of solution, limits in the methods of the invention Chromatographic condition under detect, the results are shown in Table 6.Repeatability is good as the result is shown.
6, method detection limit and quantitative limit are investigated
Three, application effect
1, using the detection side HPLC-ELSD of gentamicin C components content in gentamicin procaine of the present invention dimension B12 capsule Method detects the 47 batch gentamicin procaines dimension B12 capsule sample that different enterprises produce, and measurement gentamicin is general In Lu Kayinwei B12 capsule the case where gentamicin C components content,
Instrument and reagent: 380 high performance liquid chromatograph of Aglient 1260- ELSD;Electronic balance METTLER XS205DU; Gentamicin sulphate standard items (lot number 130326-201716, C1 content 15.9%, C1a content 15.2%, C2 content 16.9%, C2a Content 10.3%;It is provided by National Institute for Food and Drugs Control).
The sulphur for only having Chinese Pharmacopoeia to record in domestic all gentamicin sulphate preparation relevant criterions prevailing for the time being in force at present Sour injection liquid of gentamicin has included gentamicin sulphate component check item, and provides: C1Should be labelled amount 15.3%~ 28.0%, C1aIt should be 19.6%~48.0%, C of labelled amount2a+C2It should be the 28.5%~63.8% of labelled amount, four components always contain Amount is not less than labelled amount 85%, therefore this result is evaluated in this, as reference pair.Measurement result is shown in Table 7.
2, sample measurement result is analyzed
Overall distribution situation: 47 batch sample total content average values 103.3%, content range 111.5%~93.9%;C1a content Average value 33.2%, content range 25.6%~39.6%;C1 content average value 22.2%, content range 19.9%~27.0%;C2+ As a result C2a content average value 47.9%, content range 42.7%~54.5% meet regulation, qualification rate 100%.47 batch samples Product total content and each component content distribution figure are shown in FIG. 1 to FIG. 4.
Data among enterprises compare: gentamicin sulphate 4 component total content Hainan day are bright to be up to 108.5%, Zhejiang Tianrui Minimum 97.1%;C1It is trimly pharmacy 26.6%, minimum Haikou surprise power 21.8% that content is maximum;C1aMaximum content is trimly Pharmacy 36.6%, minimum Zhejiang Tianrui 29.0%; C2+C2aContent maximum Hainan day bright 51.0%, minimum trimly pharmacy 43.1%;4 4 component total contents of enterprise's sample gentamicin sulphate are all larger than 85%, and each component content meets regulation.4 enterprise's samples are total Content average value and the comparison of each component content average value are shown in Table 8 and Fig. 5~Fig. 8.
3, gentamicin sulphate raw material components measurement result and analysis
Version Chinese Pharmacopoeia gentamicin sulphate gentamicin C components item regulation in 2015: C1It should be 14%~22%, C1aIt should be 10% ~23%, C2+C2aIt should be 17%~36%, four component total contents must not be lower than 50.0%.7 batch sulphur that 7 enterprises are provided Sour gentamicin raw material is measured, as the result is shown being produced by North China Hua Luan Co., Ltd, pharmacy group except the auspicious new offer in Zhejiang Gentamicin sulphate raw material C1 content and total content be below outside prescribed limit, other API measurement results meet regulation, examine Consider the sample that this sampling observation is not extracted into the auspicious new production in Zhejiang, and the raw material lot number provided is more early, however not excluded that enterprise does not give birth to for a long time Production is improper to surplus stock preservation to lead to the underproof situation of assay.Measurement result is shown in Table 9.
It is above-mentioned as it can be seen that tieing up gentamicin C components content in B12 capsule using gentamicin procaine of the present invention HPLC-ELSD detection method, easy to operate, detection efficiency is high, and error is small, and applicability is wide;It is raw to each enterprise using this method The gentamicin procaine dimension B12 capsule of production is detected, and can fast and accurately detect that gentamicin procaine is tieed up The content of gentamicin C components in B12 capsule, to be conducive to tie up B12 to the gentamicin procaine that each enterprise produces The quality of capsule sample is determined.

Claims (2)

1. the HPLC-ELSD detection method of gentamicin C components content in a kind of gentamicin procaine dimension B12 capsule, It is characterized in that, comprising the following steps:
(1) chromatographic condition and system suitability:
It is filler, Shiseido ACR C18 4.6 × 250mm, 5 μm of chromatographic columns, with first with octadecylsilane chemically bonded silica Alcohol is mobile phase A, and 0.02mol/L trifluoroacetic acid is Mobile phase B, carries out gradient elution, flow velocity 1ml/min, column temperature 30 by table 1 ℃;
(2) prepared by solution:
The preparation of gentamicin sulphate standard solution
Gentamicin sulphate standard items 100mg is taken, it is accurately weighed, it is placed in 10mL measuring bottle, scale is dissolved and be diluted to water, is shaken It is even, it is accurate respectively to measure 1,3,5mL, it is diluted with water to 10mL, is shaken up, concentration, which is made, respectively may be about 1mg/mL, 3mg/mL, 5mg/ The standard solution of mL is 1., 2., 3.;
The preparation of test solution:
It takes this product content to mix, weighs in right amount, be equivalent to average loading amount, accurately weighed, precision plus water 5mL, shaking make sulfuric acid Gentamicin dissolution, filtering take subsequent filtrate as test solution;
(3) it measures:
Precision measures standard solution, and 1., 2., 3. each 20 μ L according to above-mentioned chromatographic condition is injected separately into liquid chromatograph, records Chromatogram calculates the equation of linear regression of standard solution each component log concentration value and corresponding peak area logarithm, phase relation Number r is not less than 0.99;It takes test solution to be measured in the same method, is calculated separately with the equation of linear regression of gentamicin each component for examination The amount C of component is corresponded in producttcx, and calculate by following formula the content Cx of each component;
In formula, Cx is the content %, u/u of gentamicin each component;CtcxContent for each component gone out by regression equation calculation mg/ml;It is averaged loading amount g for test sample;W is test sample sampling amount mg;V is test sample extension rate;Labelled amount is in terms of g.
2. the HPLC- of gentamicin C components content in gentamicin procaine dimension B12 capsule according to claim 1 ELSD detection method, which is characterized in that in step (1) chromatographic condition and system suitability, atomization temperature is 70 DEG C, air-flow Speed is 1.6SLM.
CN201910230015.XA 2019-03-26 2019-03-26 HPLC-ELSD detection method for content of gentamicin C component in gentamicin procaine vitamin B12 capsule Active CN109917036B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910230015.XA CN109917036B (en) 2019-03-26 2019-03-26 HPLC-ELSD detection method for content of gentamicin C component in gentamicin procaine vitamin B12 capsule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910230015.XA CN109917036B (en) 2019-03-26 2019-03-26 HPLC-ELSD detection method for content of gentamicin C component in gentamicin procaine vitamin B12 capsule

Publications (2)

Publication Number Publication Date
CN109917036A true CN109917036A (en) 2019-06-21
CN109917036B CN109917036B (en) 2022-04-01

Family

ID=66966746

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910230015.XA Active CN109917036B (en) 2019-03-26 2019-03-26 HPLC-ELSD detection method for content of gentamicin C component in gentamicin procaine vitamin B12 capsule

Country Status (1)

Country Link
CN (1) CN109917036B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112730666A (en) * 2020-12-23 2021-04-30 无锡济煜山禾药业股份有限公司 Method for detecting content of gentamicin C1a alkali freeze-dried powder C1a
CN113189241A (en) * 2021-05-08 2021-07-30 河北圣雪大成制药有限责任公司 Method for detecting gentamicin content and components in fermentation liquor by using HPLC-ELSD

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1303271A1 (en) * 2000-07-13 2003-04-23 PHARMACIA & UPJOHN COMPANY Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug
CN102226790A (en) * 2011-03-31 2011-10-26 宁波双伟制药有限公司 Method for determining procaine hydrochloride content in gentamycin procaine vitamin B12 particle by high performance liquid chromatography

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1303271A1 (en) * 2000-07-13 2003-04-23 PHARMACIA & UPJOHN COMPANY Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug
CN102226790A (en) * 2011-03-31 2011-10-26 宁波双伟制药有限公司 Method for determining procaine hydrochloride content in gentamycin procaine vitamin B12 particle by high performance liquid chromatography

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
WEI-WEI QIN等: "Simultaneous determination of procaine, lidocaine, ropivacaine, tetracaine and bupivacaine in human plasma by high-performance liquid chromatography", 《JOURNAL OF CHROMATOGRAPHY B》 *
刘英等: "两种方法测定硫酸庆大霉素组分和有关物质的比较", 《华西药学杂志》 *
王明娟等: "高效液相色谱-蒸发光散射检测法分析庆大霉素C组分 ", 《药物分析杂志》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112730666A (en) * 2020-12-23 2021-04-30 无锡济煜山禾药业股份有限公司 Method for detecting content of gentamicin C1a alkali freeze-dried powder C1a
CN113189241A (en) * 2021-05-08 2021-07-30 河北圣雪大成制药有限责任公司 Method for detecting gentamicin content and components in fermentation liquor by using HPLC-ELSD

Also Published As

Publication number Publication date
CN109917036B (en) 2022-04-01

Similar Documents

Publication Publication Date Title
CN106383186B (en) The HPLC analytical method of 14 kinds of vitamin contents is determined simultaneously
CN107643345A (en) A kind of method of quality control of Rhizoma Gastrodiae and its medicine materical crude slice and extract
CN109917036A (en) Gentamicin procaine ties up the HPLC-ELSD detection method of gentamicin C components content in B12 capsule
CN105388223B (en) The assay method of residual solvent in a kind of Decitabine intermediate
CN108663448A (en) Detection method in relation to substance in a kind of Amino Acid Compound Injection
CN113009003A (en) Method for detecting related substances in itopride hydrochloride preparation
CN107315059A (en) The content assaying method of rifampin and its impurity in a kind of rifampicin capsules
CN106706789A (en) Method for detecting related substances in drotaverine hydrochloride injection by high performance liquid chromatography
CN102226790A (en) Method for determining procaine hydrochloride content in gentamycin procaine vitamin B12 particle by high performance liquid chromatography
CN108802220A (en) HPLC methods measure 3 kinds of naphthoquinones constituents contents and quality standard detecting method in Asian puccoon medicinal material
CN106525994A (en) Method for determination of related substances of paracetamol and tramadol hydrochloride capsules
CN104000827B (en) A kind of pharmaceutical composition containing active ingredient hydrochloric acid nalmefene
CN111398457A (en) Method for detecting substances related to Eagliflozin influence factors under degradation condition
CN103901147B (en) A kind of assay method of dripping pills of andrographolide dissolution rate
CN100540037C (en) A kind of detection method of infantile lung clearing phlegm transforming preparation
CN106932347B (en) A kind of mezlocillin and its quality index detection method
CN104678011B (en) A kind of detection method of TONGMAIYANGXINWAN
CN104965031B (en) Content measuring method for compound ketoprofen and omeprazole sustained-release capsules
CN109142585A (en) A kind of detection method of sodium pantothenate isomers
CN108120782A (en) A kind of assay method of ivermectin chewable tablets dissolution rate
CN103860461A (en) Medicinal composition containing active component ambroxol hydrochloride
CN104644748B (en) A kind of preparation method of stability-enhanced compound glycyrrhiza oral solution
CN107884496B (en) Method for determining content of succinic acid in trelagliptin succinate
CN111239319A (en) Method for measuring content of panax japonicus saponin IVa in laryngopharynx clearing oral liquid
CN102657646B (en) Medicinal composition and preparation thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant